Overview

Tocilizumab for the Treatment of Familial Mediterranean Fever

Status:
Completed
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
Adult patients with Familial Mediterranean Fever, who have active disease
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Tuebingen